Equity
€1,000 from €122,228 in 2021
Equity fell by 99% in 4 years.
WIWAMED
Lifetime
7 annual accounts with figures on one time axispeak €199,876 (2025)
€199,876▲ 142%
peak €130,182 (2025)
€130,182▲ 190%
peak €122,228 (2021)
€1,000unchanged
€187,471▲ 81.3%
Board1 name since 2019
1 director
Documentsfilings and deeds
17-08-202617 days late
2025micro format
Gross margin from €82,454 to €199,876Result from €44,929 to €130,182Dividend €130,182Debts from €103,416 to €187,471
Key points
from the 2025 annual accountsResult
€130,182 ▲ 190%
The result rose in 2025 from €44,929 to €130,182.
Debts
€187,471 99% of the balance sheet
Suppliers 2%Taxes and wages 29%Other 69%
Filings
7 annual accounts 7 late
The 2019 accounts came latest: 90 days after the end of the period.
At the same address
15 companies
Position in the sector
0.5%
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,334 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as WIWAMED has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for WIWAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0738916801
Incorporation
Founding capital of €1,000, 100 shares · Founder: (comparant) · Appointment: (director) · published on 12-12-2019 · Gazette deed
First establishment
Stationstraat 42, Etterbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| WIWAMED Etterbeek | €188,471 | €199,876 | 0.5% | - |
| S.H. Respiratory Medicine Sint-Genesius-Rode | €190,967 | €200,687 | 65.1% | - |
| Dokter Jona Vercammen Mol | €178,951 | €201,508 | 89.1% | - |
| Dr. Raphaël Lapré Schoten | €178,532 | €197,273 | 81.3% | - |
| Dr. Roel Mestrum Linter | €181,851 | €198,169 | 72.6% | - |
| LEJON-URG Diepenbeek | €181,524 | €203,004 | 85.3% | 0 |
| KNAFEL MARJORIE Fontaine-l'Evêque | €181,295 | €210,926 | 5.5% | - |
These companies have the same main activity as WIWAMED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €179,000 and €191,000, founded between 2019 and 2020.
Official details
Source: KBO- Status
- Active since 10-12-2019Normal situation
- Registered office
- 17 active companies are registered at this addressSource: KBO register, as of 15 November 2026.
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Joint committee
- 335Services and support for business and the self-employed · annual accounts 2021
- Establishment unit
- 2.297.065.2151040 Etterbeek, since 10-12-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 17-12-2025
Annual accounts 2025
- ≈ €370,000estimated
- €188,471▲ 80.5%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 17-08-2026
Insights on WIWAMED
WIWAMED files the micro format. That format states no turnover. The gross margin rose from €71,043 in 2020 to €199,876 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about WIWAMED
- What is the company number of WIWAMED?
- The company number of WIWAMED is 0738.916.801. The VAT number is the same number with BE in front: BE 0738.916.801.
- Where is WIWAMED based?
- The registered office is at Stationstraat 42, 1040 Etterbeek.Company details
- What does WIWAMED do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of WIWAMED?
- WIWAMED is a private limited company (BV).
- When was WIWAMED founded?
- WIWAMED was founded on 10-12-2019.
- Is WIWAMED still active?
- Yes, WIWAMED is an active enterprise in the KBO register.
- How many employees does WIWAMED have?
- WIWAMED had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does WIWAMED fall under?
- In its 2021 annual accounts, WIWAMED states joint committee 335 (Services and support for business and the self-employed).
- What is the turnover of WIWAMED?
- The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €199,876 and 40 comparable companies (NACE 86220). It probably lies between €320,000 and €490,000.
- Is WIWAMED profitable?
- In financial year 2025, WIWAMED made a profit of €130,182.
- Where can I find the annual accounts of WIWAMED?
- WIWAMED filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of WIWAMED due?
- WIWAMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.